Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 851 to 860 of 1040
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK MIA 50813 Insp GMP 50813/16842-0018[H] GMPC

ELANCO SPEKE OPERATIONS, FLEMING ROAD, SPEKE, LIVERPOOL, L24 9LN, UNITED KINGDOM

UNITED KINGDOM
UK MIA 17872 Insp GMP/GDP 17872/11666182-0004[H] GMPC

MEDICAL GAS SOLUTIONS LIMITED, UNIT 10 WATLING STREET BUSINESS PARK, WATLING STREET, CANNOCK, WS11 9XG, UNITED KINGDOM

UNITED KINGDOM
UK MIA 6183 Insp GMP/GDP 6183/17005-0008[H] GMPC

AIR PRODUCTS PLC, SHARP STREET, WALKDEN, WORSLEY, MANCHESTER, M28 3WA, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 1384 Insp GMP/IMP 1384/7203285-0004[I] GMPC

UNIVERSITY OF EDINBURGH - INVESTIGATIONAL SUPPLIES GROUP, 1 GEORGE SQUARE, EDINBURGH, EH8 9JZ, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 47794 Insp GMP/IMP 47794/28762-0019[I] GMPC

PHARMARON UK LIMITED, PEGASUS WAY, CROWN BUSINESS PARK, RUSHDEN, NN10 6ER, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 10410 Insp GMP/IMP 11059/56091-0020[I] GMPC

MANDEVILLE MEDICINES, STOKE MANDEVILLE HOSPITAL, MANDEVILLE ROAD, AYLESBURY, HP21 8AL, UNITED KINGDOM

UNITED KINGDOM
UK MIA 14163 Insp GMP 14163/12336-0012[H] GMPC

KIMAL MANUFACTURING DIVISION, UNIT 62, SHERWOOD ROAD, ASTON FIELDS INDUSTRIAL ESTATE, BROMSGROVE, B60 3DR, UNITED KINGDOM

UNITED KINGDOM
UK API 33889 Insp GMP 33889/596852-0006 [V] GMPC

BASF PHARMA (CALLANISH) LIMITED, BREASCLETE, ISLE OF LEWIS, HS2 9ED, UNITED KINGDOM

UNITED KINGDOM
UK API 33889 Insp GMP 33889/596852-0006 [H] GMPC

BASF PHARMA (CALLANISH) LIMITED, BREASCLETE, ISLE OF LEWIS, HS2 9ED, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 5866 Insp IMP 5866/92252-0006[I] GMPC

GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED, ADDENBROOKE'S HOSPITAL BOX 128, CLINICAL RESEARCH UNIT, HILLS ROAD, CAMBRIDGE, CB2 0GG, UNITED KINGDOM

UNITED KINGDOM

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX